NCT02206048View on ClinicalTrials.gov

Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 2, 2015

Primary Completion Date

April 21, 2021

Study Completion Date

April 21, 2021

Conditions
Cervix Carcinoma
Interventions
DRUG

Proflavine

0.01% proflavine solution topically applied to cervix before high-resolution microendoscopy (HRME) imaging.

PROCEDURE

High-Resolution Microendoscopy (HRME) Imaging

in-vivo high-resolution microendoscopy (HRME) images of cervical adenocarcinoma in situ (AIS) performed immediately prior to conization.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT02206048 - Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix | Biotech Hunter | Biotech Hunter